Inglewood Ventures
10
14M
6
3
0.40
3
- Stages of investment
- Areas of investment
Summary
The venture was found in North America in United States. The main office of represented VC is situated in the San Diego.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Inglewood Ventures, startups are often financed by Sanderling Ventures, Life Sciences Partners, Biofrontier Partners. The meaningful sponsors for the fund in investment in the same round are Sanderling Ventures, Life Sciences Partners, GeneChem. In the next rounds fund is usually obtained by Sanderling Ventures, Bioventures Investors, Mitsui Global Investment.
This Inglewood Ventures works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Inglewood Ventures the average startup value is 100-500 millions dollars. The increased amount of exits for fund were in 2008. The important activity for fund was in 2001. The fund is constantly included in less than 2 investment rounds annually. Considering the real fund results, this VC is 18 percentage points more often commits exit comparing to other organizations.
Among the most popular fund investment industries, there are Pharmaceutical, Health Care. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Cylene Pharmaceuticals, Genicon Sciences, GeneFormatics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 3
- Exits
- 3
- Follow on index
- 0.40
- Investments by industry
- Health Care (6)
- Biotechnology (5)
- Therapeutics (4)
- Medical (3)
- Medical Device (2) Show 2 more
- Investments by region
-
- United States (10)
- Peak activity year
- 2001
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 61M
- Group Appearance index
- 0.90
- Avg. company exit year
- 7
- Avg. multiplicator
- 2.89
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Conforma Therapeutics | 18 Sep 2003 | Therapeutics | Late Stage Venture | 30M | United States, California, San Diego |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.